| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/01/1992 | CA2106464A1 Malaria recombinant poxvirus vaccine |
| 10/01/1992 | CA2106069A1 Recombinant virus vectors encoding human papillomavirus proteins |
| 10/01/1992 | CA2105993A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | CA2105876A1 Gene mutated in colorectal cancer of humans |
| 09/30/1992 | WO1992017586A1 Protein having a cytokinin-type activity, recombinant dna coding for this protein, transformed cells and micro-organisms |
| 09/30/1992 | WO1992017525A1 Polyamino acid superabsorbents |
| 09/30/1992 | EP0506651A2 Pharmaceutical preparation based on plasma proteins |
| 09/30/1992 | EP0506574A1 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 09/30/1992 | EP0506561A1 Process for enzymatic synthesis of macrolactone |
| 09/30/1992 | EP0506477A1 Vascular endothelial cell growth factor C subunit |
| 09/30/1992 | EP0506377A2 Calmodulin binding protein |
| 09/30/1992 | EP0506040A1 Mutant AOX2 promotor, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
| 09/30/1992 | EP0506032A1 Receptor purification method |
| 09/30/1992 | EP0505962A1 Method and pre-assembled kit for obtaining fibrogen in a full sterile environment |
| 09/30/1992 | EP0505941A2 Peptifluorin and neopeptifluorin |
| 09/30/1992 | EP0505921A2 Process for the preparation of mature polypeptides by enzymatic cleavage with factor XA |
| 09/30/1992 | EP0505908A1 Chimaeric polypeptides |
| 09/30/1992 | EP0505846A1 Process for converting fused protein into active type human motilin analogues and purifying the analogues |
| 09/30/1992 | EP0505811A2 Improved acidic fibroblast growth factor (aFGF) and its preparation |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505680A1 Octapeptide or heptapeptide derivatives, a process for preparing them as well as medicaments containing these compounds and the use of them |
| 09/30/1992 | EP0505552A1 Megakaryocyte maturation factors |
| 09/30/1992 | EP0505497A1 Wound treatment employing biologically active peptides |
| 09/30/1992 | EP0505488A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
| 09/30/1992 | EP0505405A1 Dna, constructs, cells and plants derived therefrom |
| 09/30/1992 | EP0505387A1 Dna binding proteins including androgen receptor |
| 09/30/1992 | EP0505385A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety |
| 09/30/1992 | EP0307472B1 Immunogenic recombinant yeast expression product and method for purifying it |
| 09/30/1992 | CN1064892A Recombinant virus vectors |
| 09/30/1992 | CN1064891A Vaccines |
| 09/30/1992 | CA2064253A1 Method and pre-assembled kit for obtaining fibrin sponge in a fully sterile environment |
| 09/29/1992 | WO1992017596A1 Dna, dna constructs, cells and plants derived therefrom |
| 09/29/1992 | WO1992017568A1 A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER |
| 09/29/1992 | WO1992017501A1 Isolated osteogenic factor |
| 09/29/1992 | WO1992017196A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | US5151511 Codes for chicken and turkeys for growth agents |
| 09/29/1992 | US5151509 Gene encoding serine protease inhibitor |
| 09/29/1992 | US5151508 Promoter region for DNA sequences which encode the precursor of the human A4 amyloid protein |
| 09/29/1992 | US5151502 Method for solubilizing membrane receptor proteins |
| 09/29/1992 | US5151501 Method for solubilization and naturation of somatotropins utilizing sulfolane |
| 09/29/1992 | US5151498 Immunomodulators and mitogenic agents by extraction, precipitation and filtration |
| 09/29/1992 | US5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
| 09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 09/29/1992 | US5151364 Expression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmids |
| 09/29/1992 | US5151363 Nematocides |
| 09/29/1992 | US5151361 Host cells expressing gibbon ape leukemia virus receptor |
| 09/29/1992 | US5151350 Cloned genes encoding recombinant protein a |
| 09/29/1992 | US5151349 Method for expressing polypeptide having anti-tumor activity |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | US5151267 Bovine herpesvirus type 1 polypeptides and vaccines |
| 09/29/1992 | CA2107088A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | CA2106190A1 Cdna clone encoding a human norepinephrine transporter |
| 09/29/1992 | CA2106090A1 Dna, dna constructs, cells and plants derived therefrom |
| 09/29/1992 | CA2064131A1 Receptor purification method |
| 09/29/1992 | CA2064114A1 Somatostatin receptor |
| 09/29/1992 | CA2061476A1 Peptifluorin and neopeptifluorin |
| 09/28/1992 | WO1992017192A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2107100A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/27/1992 | WO1992017612A1 Assay for non-a non-b hepatitis |
| 09/27/1992 | WO1992017502A1 Adsorbed cellular fibronectin and process for separating and purifying fibronectins |
| 09/27/1992 | CA2082924A1 Assay for non-a non-b hepatitis |
| 09/23/1992 | WO1992016652A1 Nucleic acid probes useful for the detection of mycobacterium tuberculosis |
| 09/23/1992 | WO1992016634A1 A process for producing heme proteins |
| 09/23/1992 | WO1992016234A1 Method of modulating mammalian t-cell response |
| 09/23/1992 | EP0505311A2 A process for producing heme proteins |
| 09/23/1992 | EP0505267A1 Process for chemical modification of proteins |
| 09/23/1992 | EP0505210A2 Assay for measuring the degradation of type I collagen |
| 09/23/1992 | EP0505207A1 Biological control agents |
| 09/23/1992 | EP0505151A2 Preparation of the penicilline binding protein 2A from staphylococcus aureus 27R, purification and use in a resistant-assay |
| 09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
| 09/23/1992 | EP0505034A2 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/23/1992 | EP0505012A2 Means for amplifying nucleic acid sequences |
| 09/23/1992 | EP0504919A2 Mirabilis jalapa antiviral protein |
| 09/23/1992 | EP0504823A2 Method for producing human serum albumin |
| 09/23/1992 | EP0504751A1 Method for the preparation of interleukin 6 |
| 09/23/1992 | EP0504423A1 Method and kit for immunoassay of propeptide of osteocalcin and proosteocalcin |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
| 09/23/1992 | EP0504361A1 Megakaryocyte and platelet growth, production and composition |
| 09/23/1992 | EP0504350A1 Antibodies directed against cd3 |
| 09/23/1992 | EP0504349A1 BIOCONVERSIONS CATALYZED BY THE TOLUENE MONOOXYGENASE OF $i(PSEUDOMONAS MENDOCINA) KR-1 |
| 09/23/1992 | EP0504335A1 A fibronectin binding peptide |
| 09/23/1992 | EP0504291A1 Novel proteins with oncostatin m activity and process for their preparation |
| 09/23/1992 | EP0504289A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product |
| 09/23/1992 | EP0504288A1 Fluorinated poly(naphthyl ethers) |
| 09/23/1992 | EP0504257A1 [Ala IL-8] 77 AS A LEUKOCYTE ADHESION INHIBITOR |
| 09/23/1992 | EP0504253A1 DNA PROBES SPECIFIC FOR $i(PLASMODIUM VIVAX) |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504191A1 Method and composition for the treatment of mammalian hiv infection. |
| 09/23/1992 | EP0504177A1 A mammalian cytokine, il-11 |
| 09/23/1992 | EP0504168A1 Synthetic calcitonin peptides |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CN1064704A Curculin b and dna encoding same, and process for production thereof |
| 09/23/1992 | CN1064684A Insecticidally effective peptides |
| 09/23/1992 | CA2106869A1 Nucleic acid probes useful fo the detection of mycobacterium tuberculosis |
| 09/23/1992 | CA2106567A1 Method of modulating mammalian t-cell response |
| 09/23/1992 | CA2106485A1 Process for producing heme proteins |
| 09/23/1992 | CA2061507A1 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived thereform |